HEMOSTASIS COAGULATION RESEARCH REAGENTS HUMAN PLASMAS HIGH FACTOR PLASMAS

High Factor V plasma (acquired) > 150 %

Advantages

Minimize test time. Ready to use.

Informations

Factor V (FV) is a protein mainly synthesized by the liver. It is the enzymatic cofactor of FX and is activated in FVa by thrombin and / or FXa. It forms with FXa a complex which, in the presence of phospholipids and calcium, activates FII to FIIa. The FVa is neutralized by the PCa.

Documentation

Download the product sheet

Price list, safety data sheets and notices are accessible to our registered customers.

References

6-PP05H	Vial	1 x 1.0 mL

Special plasmas are derived from patients with acquired deficiency, severe or moderate, or presenting a particular profile. No buffer or preservatives are added. Quickly frozen at -80° C, the plasma maintains perfectly intact the matrix. All plasmas are stable when stored at -40° C to -80° C. We carefully pack with dry ice during shipment. No additive or preservative. Expiry date > 1 year. Plastic vials.

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Reactive in liquid form.
	Reactive in lyophilized form.
	Reactive in frozen form.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.
	Manufacturer.
	Importer
	Distributor.

HEMOSTASIS COAGULATION RESEARCH REAGENTS HUMAN PLASMAS HIGH FACTOR PLASMAS

High Factor V plasma (acquired) > 150 %

Advantages

Informations

Documentation

Price list, safety data sheets and notices are accessible to our registered customers.

References

Cryopep Catalogue
Thrombosis Haemostasis 2024

Cryopep Catalogue
Haemostasis Research 2024

Cryopep HUMAN PLASMAS

Product sheet High Factor V plasma (acquired) > 150 %

Related products: 9

Factor XIII High > 150 % (acquired)

High Factor II plasma (acquired) > 150 %

High Factor II plasma (G20210A positive mutation) > 150%

High Factor IX plasma > 150 % (acquired)

High Factor X plasma > 150 % (acquired)

High Factor XI plasma > 150 % (acquired)

High Factor XII plasma > 150 % (acquired)

High FVII plasma 100-150 % (acquired)

High FVIII plasma > 150 % (acquired)

You must identify yourself to search for a certificate of analysis

HEMOSTASIS COAGULATION RESEARCH REAGENTS HUMAN PLASMAS HIGH FACTOR PLASMAS

High Factor V plasma (acquired) > 150 %

Advantages

Informations

Documentation

Price list, safety data sheets and notices are accessible to our registered customers.

References

Related products: 9